Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2005-06-14
2005-06-14
Qazi, Sabiha (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S171000, C514S177000, C514S178000, C514S182000, C514S841000, C514S843000
Reexamination Certificate
active
06906049
ABSTRACT:
The present invention relates to the field of chemistry and more particularly to that of therapeutic chemistry.The invention relates more particularly to novel contraceptive compositions formed from a progestative agent and an oestrogen.The invention relates specifically to novel pharmaceutical contraceptive compositions, characterized in that they contain, as active ingredients, a nomegestrol ester and oestradiol, in combination or admixture with an inert, non-toxic, pharmaceutically-acceptable vehicle or diluent which is suitable for oral administration.
REFERENCES:
patent: 6500814 (2002-12-01), Hesch
patent: 2754179 (1998-04-01), None
Jamin, C. (POPLINE database, abstract of Revue Francaise De Gynecologie Et D Obsterique, 1992, 87(6):370-6).
Paris Jacques
Thomas Jean Louis
Dennison Schultz Dougherty & MacDonald
Laboratoire Theramex
Qazi Sabiha
LandOfFree
Contraceptive medicine based on a progestational agent and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contraceptive medicine based on a progestational agent and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contraceptive medicine based on a progestational agent and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3467921